RECRUITING

Restoration of Hand Function in Cervical SCI

Talk to us

Conditions

Spinal Cord Injury CervicalCervical Spinal Cord Injury (SCI)

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate a new method of restoring hand function to people with spinal cord injury. Current methods to restore hand function include tendon transfers and nerve transfers. This study will evaluate the grasp strength that can be achieved with a small, implantable stimulator. KeyGrip is an investigational device that works by activating paralyzed muscles with low levels of electrical current. The word "investigational" means the study device is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA) for the use being studied. Hypothesis. The study is designed to explore the feasibility of this approach; no hypothesis is planned at this stage

Official Title

Evaluation of a Simple Neuroprosthesis for Restoration of Hand Function in Cervical Spinal Cord Injury

Quick Facts

Study Start:2025-01-01
Study Completion:2030-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06611748

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or female adults 18 years of age or older;
  2. * Cervical spinal cord injury as defined by: a) International Standard for Neurological Classification of Spinal Cord Injury motor level of C1 through C7; and b) American Spinal Injury Association Impairment Scale (AIS) grade A, B, or C;
  3. * Six months or more post-injury (neurostability);
  4. * Neurologically stable following any nerve transfers affecting the upper extremity (typically, one-year post-surgery);
  5. * Musculoskeletally and neurologically stable following any tendon transfers affecting the upper extremity (typically 6 months post-surgery).
  6. * Peripheral nerve innervation to upper extremity muscles, including Grade 3/5 or higher Stimulated Manual Muscle Testin at least two of the muscles in one arm:
  7. * Good proximal voluntary upper extremity strength as defined by biceps/ brachialis / brachioradialis strength of 2/5 or higher on Manual Muscle Testing the side intended for implantation;
  8. * Medically stable; and
  9. * Able to understand and provide informed consent;
  1. * Other neurological conditions (Multiple Sclerosis, diabetes with peripheral nerve involvement);
  2. * Associated peripheral nerve / brachial plexus injury;
  3. * Progressive Spinal Cord Injury;
  4. * Active implantable medical device (AIMD) such as a pacemaker or defibrillator;
  5. * Active untreated infection such as urinary tract infection or pneumonia;
  6. * Active pressure injury;
  7. * History of coagulopathy, HIV, cardiopulmonary disease, bradycardia, poorly controlled autonomic dysreflexia, or chronic obstructive pulmonary disease that would preclude safe participation in the trial as determined by the investigator;
  8. * Unhealed fractures that prevent functional use of arm;
  9. * Extensive upper extremity denervation (fewer than two excitable hand muscles);
  10. * Involvement in other ongoing clinical studies that exclude concurrent involvement in this study;
  11. * Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant based on self-report); Urine or serum testing will happen during the pre-surgery evaluation.
  12. * Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study;
  13. * Other significant medical findings that, in the opinion of the investigator, preclude safe participation in the trial

Contacts and Locations

Study Contact

Kim Walsh, OTR/L
CONTACT
216-957-3512
kwalsh3@metrohealth.org
Krissy Hansen, PT
CONTACT
216-957-3584
khansen1@metrohealth.org

Principal Investigator

Megan Moynahan
PRINCIPAL_INVESTIGATOR
MetroHealth Medical Center

Study Locations (Sites)

MetroHealth Medical Center
Cleveland, Ohio, 44109
United States

Collaborators and Investigators

Sponsor: MetroHealth Medical Center

  • Megan Moynahan, PRINCIPAL_INVESTIGATOR, MetroHealth Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-01
Study Completion Date2030-11

Study Record Updates

Study Start Date2025-01-01
Study Completion Date2030-11

Terms related to this study

Keywords Provided by Researchers

  • Cervical Spinal Cord Injury (SCI)

Additional Relevant MeSH Terms

  • Spinal Cord Injury Cervical